Skip to Content

Influenza A (H1N1) 2009 Monovalent Vaccine Approval History

FDA Approved: Yes (First approved September 15, 2009)
Brand name: Influenza A (H1N1) 2009 Monovalent Vaccine
Generic name: H1N1 influenza virus vaccine
Company: CSL Limited; Novartis Vaccines and Diagnostics Limited; Sanofi Pasteur, Inc.; MedImmune LLC
Treatment for: Influenza Prophylaxis

Influenza A (H1N1) 2009 Monovalent Vaccine is an inactivated influenza virus vaccine indicated for active immunization of persons 6 months of age and older against influenza disease caused by pandemic (H1N1) 2009 virus.

Development History and FDA Approval Process for Influenza A (H1N1) 2009 Monovalent Vaccine

Nov 13, 2009Approval FDA Expands Approved Use of H1N1 Vaccines to Include Infants and Children
Sep 16, 2009Approval FDA Approves Vaccines for 2009 H1N1 Influenza Virus

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.